Maternal immune responses and risk of infant infection with HIV-1 after a short course Zidovudine in a cohort of HIV-1 infected pregnant women in rural Kenya.
暂无分享,去创建一个
J. Vulule | P. Tukei | D. Koech | R. Lihana | E. Songok | S. Mpoke | E. Makokha | A. Chemtai | F. Andayi | N. Adungo | N. Kobayashi | A. Orago
[1] R. Salamon,et al. Preventing mother-to-child transmission of HIV-1 in Africa in the year 2000 , 2000, AIDS.
[2] Bruun,et al. Early Changes in Peripheral Blood T Cell Subsets Induced by Antiretroviral Treatment of Human Immunodeficiency Virus‐1 Positive Individuals , 2000, Scandinavian journal of immunology.
[3] M. Newell. Vertical transmission of HIV-1 infection. , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[4] D. Shapiro,et al. Risk factors for perinatal human immunodeficiency virus transmission in patients receiving zidovudine prophylaxis. Pediatric AIDS Clinical Trials Group protocol 076 Study Group. , 1999, Obstetrics and gynecology.
[5] J. Karon,et al. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial , 1999, The Lancet.
[6] Mother-to-child transmission of human immunodeficiency virus in Italy: temporal trends and determinants of infection. The Italian Collaborative Study on HIV infection in pregnancy. , 1999, Human reproduction.
[7] International multicentre pooled analysis of late postnatal mother‐to‐child transmission of HIV‐1 infection , 1998 .
[8] S. Welles,et al. The inter-relation of maternal immune competence, HIV-1 viral load, and nutritional status in preventing vertical transmission: an alternative to chemoprophylaxis? , 1998, Medical hypotheses.
[9] J. Benito,et al. Quantitative alterations of the functionally distinct subsets of CD4 and CD8 T lymphocytes in asymptomatic HIV infection: changes in the expression of CD45RO, CD45RA, CD11b, CD38, HLA-DR, and CD25 antigens. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[10] W. Andiman,et al. Reduction in the risk of vertical transmission of HIV-1 associated with treatment of pregnant women with orally administered zidovudine alone. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[11] P. Nourjah,et al. Changes in CD4+ and CD8+ cell levels during pregnancy and post partum in women seropositive and seronegative for human immunodeficiency virus-1. , 1996, American journal of obstetrics and gynecology.
[12] R. Rydman,et al. CD4+ lymphocytes in perinatal human immunodeficiency virus (HIV) infection: evidence for pregnancy-induced immune depression in uninfected and HIV-infected women. , 1995, The Journal of infectious diseases.
[13] G. Msemo,et al. Predictive markers for mother-to-child transmission of HIV-1 in Dar es Salaam, Tanzania. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[14] T. Felzmann,et al. A single laser flow cytometry method to evaluate the binding of three antibodies. , 1990, Journal of immunological methods.
[15] J. Castilla,et al. Decreased levels of circulating CD4+ T lymphocytes during normal human pregnancy. , 1989, Journal of reproductive immunology.